Author: Efefur Y.

Moderna shares soared by as much as 150% on Wednesday after the company and Merck announced positive late-stage trial results for a personalized mRNA melanoma vaccine, marking a major breakthrough in skin cancer treatment.

The Trump administration used Iraqi Kurdish President Nechirvan Barzani as a secret backchannel to Iran’s Revolutionary Guard in May, but the effort has not produced a deal.